Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-030522
Filing Date
2010-05-26
Accepted
2010-05-26 16:56:51
Documents
1
Period of Report
2010-05-24

Document Format Files

Seq Description Document Type Size
1 v186466_ex.html 4  
1 v186466_ex.xml 4 3154
  Complete submission text file 0001144204-10-030522.txt   4912
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Issuer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22322 20TH AVENUE SE STE 150 BOTHELL WA 98021
Business Address
BOYNTON ALTON L (Reporting) CIK: 0001253935 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-33393 | Film No.: 10860093